Actuarial review and estimates for prescription drug & medicare ADV plan (deloitte)

Active Awarded Last action

Contract number
75FCMC23F0021
Awardee
Awarding agency
Obligated
$15,831,531

Award facts

Contract value 83% obligated
  • $15,831,531.00 Current, with exercised options
  • $19,187,406.00 Potential, with all options
Completion date 69% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Windsor Mill, Milford Mill, MD 21244, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00008 $3,899,222
Funding Only Action P00007 $801,512
Other Administrative Action P00006 $0
Other Administrative Action P00005 · EOI::defend the spend (february 6, 2025)::EOI modification to descope non-essential consulting service $3,161,980
Supplemental Agreement for work within scope P00004 -$605,620
Exercise an Option P00003 $4,336,574
Other Administrative Action P00002 $0
Other Administrative Action P00001 -$61,427
Original award $4,299,290

About this award

Deloitte Consulting LLP was awarded a delivery order valued at $19.2 million by the Centers for Medicare and Medicaid Services (CMS) for actuarial review and estimates related to prescription drug plans and Medicare Advantage plans. The contract was awarded on May 1, 2023, with an ultimate completion date of April 30, 2028, and operates under a firm fixed-price structure with no small business set-aside. The work will be performed in Windsor Mill and Milford Mill, Maryland, and represents a child contract under a larger indefinite delivery/indefinite quantity vehicle, enabling CMS to access specialized actuarial services on a flexible task-order basis.

This engagement aligns with CMS's core mission of administering Medicare and Medicaid programs, where actuarial analysis is critical for evaluating the financial and demographic implications of prescription drug coverage and Medicare Advantage plan offerings. Deloitte's selection reflects the firm's extensive federal consulting presence and demonstrated capability in providing complex analytical and technical services to civilian health agencies. As a large business contractor, Deloitte competes for unrestricted federal procurements and frequently engages small business subcontractors to support service delivery across its federal engagements.

Quick answers

Who was awarded contract 75FCMC23F0021?

75FCMC23F0021 was awarded to Deloitte Consulting LLP by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on May 1, 2023.

How much is contract 75FCMC23F0021 worth?

The government has obligated $15,831,531 on 75FCMC23F0021. Its potential value, with all options, is $19,187,406.

Is contract 75FCMC23F0021 an order under another contract?

Yes. 75FCMC23F0021 is a delivery order under 47QRAA18D001P, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75FCMC23F0021 competed?

The extent of competition for 75FCMC23F0021 was full and open competition. The government received 7 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award